M Huerta
Overview
Explore the profile of M Huerta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Castedo B, Camblor D, Martin-Arana J, Carbonell-Asins J, Garcia-Mico B, Gambardella V, et al.
Ann Oncol
. 2024 Dec;
36(3):263-276.
PMID: 39675560
Background: Circulating tumor DNA (ctDNA) analysis has emerged as a minimally invasive tool for detecting minimal residual disease (MRD) in colorectal cancer (CRC) patients. This enables dynamic risk stratification, earlier...
2.
Mendoza-Cano O, Trujillo X, Huerta M, Rios-Silva M, Lugo-Radillo A, Bricio-Barrios J, et al.
Public Health
. 2024 Aug;
235:167-172.
PMID: 39141965
Objectives: To assess factors associated with the risk of severe disease in children aged 5 years or younger with laboratory-confirmed respiratory syncytial virus (RSV) infection. Study Design: We conducted a...
3.
Gimeno-Valiente F, Martin-Arana J, Tebar-Martinez R, Gambardella V, Martinez-Ciarpaglini C, Garcia-Mico B, et al.
ESMO Open
. 2023 Nov;
8(6):102051.
PMID: 37951129
Background: In the setting of localized colon cancer (CC), circulating tumor DNA (ctDNA) monitoring in plasma has shown potential for detecting minimal residual disease (MRD) and predicting a higher risk...
4.
Guzman-Esquivel J, Mendoza-Cano O, Trujillo X, Huerta M, Rios-Silva M, Lugo-Radillo A, et al.
Public Health
. 2023 Aug;
222:175-177.
PMID: 37552926
Objective: This study aimed to evaluate the performance of the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) case definitions for influenza-like illness (ILI) in diagnosing...
5.
Murillo-Zamora E, Mendoza-Cano O, Huerta M, Rios-Silva M, Lugo-Radillo A, Benites-Godinez V, et al.
Public Health
. 2023 Jul;
221:181-183.
PMID: 37473650
Objective: The objective of this study was to assess the survival experience of children hospitalized with laboratory-confirmed respiratory syncytial virus (RSV) infection due to bronchiolitis. Study Design: This was a...
6.
Santos-Lasaosa S, Belvis R, Cuadrado M, Diaz-Insa S, Gago-Veiga A, Guerrero-Peral A, et al.
Neurologia (Engl Ed)
. 2022 Jun;
37(5):390-402.
PMID: 35672126
Introduction: It has been observed in recent years that levels of such molecules as calcitonin gene-related peptide (CGRP) and, to a lesser extent, the pituitary adenylate cyclase-activating peptide are elevated...
7.
Murillo-Zamora E, Trujillo X, Huerta M, Rios-Silva M, Lugo-Radillo A, Baltazar-Rodriguez L, et al.
Public Health
. 2022 May;
207:105-107.
PMID: 35594806
Objective: This study aimed to identify factors predicting pneumonia in adults with coronavirus disease 2019 (COVID-19) during the Omicron variant (B.1.1.529) emergence. We also evaluated, in fully vaccinated (BNT162b2 or...
8.
Murillo-Zamora E, Trujillo X, Huerta M, Rios-Silva M, Baltazar-Rodriguez L, Guzman-Esquivel J, et al.
Public Health
. 2022 Jan;
204:9-11.
PMID: 35085915
Objectives: This study aimed to evaluate factors associated with the risk of COVID-19 pneumonia in children (aged <10 years) and adolescents (aged 10-19 years) before (March 2020-April 2021) and during...
9.
Gonzalez-Oria C, Belvis R, Cuadrado M, Diaz-Insa S, Guerrero-Peral A, Huerta M, et al.
Neurologia (Engl Ed)
. 2020 Sep;
36(3):229-240.
PMID: 32917437
Introduction: Medication overuse headache is a secondary headache in which the regular or frequent use of analgesics can increase the frequency of the episodes, causing the transition from episodic to...
10.
Tarazona N, Roda D, Rosello S, Huerta M, Cervantes A
Ann Oncol
. 2020 Jul;
31(10):1287-1288.
PMID: 32710931
No abstract available.